Abstract:Cholangiopathies, which affect extrahepatic bile ducts (EHBDs), include biliary atresia, primary sclerosing cholangitis, and cholangiocarcinoma. They have no effective therapeutic options. Tools to study EHBD are very limited. Our purpose was to develop an organ-specific, versatile, adult stem cell-derived, preclinical cholangiocyte model that can be easily generated from wild type and genetically engineered mice. Thus, we report on the novel technique of developing an EHBD organoid (EHBDO) culture system from adult mouse EHBDs. The model is cost-efficient, able to be readily analyzed, and has multiple downstream applications. Specifically, we describe the methodology of mouse EHBD isolation and single cell dissociation, organoid culture initiation, propagation, and long-term maintenance and storage. This manuscript also describes EHBDO processing for immunohistochemistry, fluorescent microscopy, and mRNA abundance quantitation by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). This protocol has significant advantages in addition to producing EHBD-specific organoids. The use of a conditioned medium from L-WRN cells significantly reduces the cost of this model. The use of mouse EHBDs provides almost unlimited tissue for culture generation, unlike human tissue. Generated mouse EHBDOs contain a pure population of epithelial cells with markers of endodermal progenitor and differentiated biliary cells. Cultured organoids maintain homogenous morphology through multiple passages and can be recovered after a long-term storage period in liquid nitrogen. The model allows for the study of biliary progenitor cell proliferation, can be manipulated pharmacologically, and may be generated from genetically engineered mice. Future studies are needed to optimize culture conditions in order to increase plating efficiency, evaluate functional cell maturity, and direct cell differentiation. Development of co-culture models and a more biologically neutral extracellular matrix are also desirable.

Cholangiocyte organoids to study drug-induced injury

Exploiting the plasticity of cholangiocytes to repair the biliary tree

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Cholangiocyte organoids can repair bile ducts after transplantation in the human liver

Bioengineered Tubular Biliary Organoids

Modeling bile duct ischemia and reoxygenation injury in human cholangiocyte organoids for screening of novel cholangio-protective agents

Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma

Human Bile Contains Cholangiocyte Organoid-Initiating Cells Which Expand as Functional Cholangiocytes in Non-canonical Wnt Stimulating Conditions

Human branching cholangiocyte organoids recapitulate functional bile duct formation

Liver Organoids, Novel and Promising Modalities for Exploring and Repairing Liver Injury

A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia

[Drug-induced bile duct injury: progress and challenges]

Extrahepatic Bile Duct Organoids as a Model to Study Ischemia/Reperfusion Injury During Liver Transplantation

Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids

A spatiotemporal atlas of cholestatic injury and repair in mice

A novel model to study mechanisms of cholestasis in human cholangiocytes reveals a role for the SIPR2 pathway

Insight to Biofabrication of Liver Microtissues for Disease Modeling: Challenges and Opportunities

Generation of liver bipotential organoids with a small-molecule cocktail

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages

The New Frontier in Regenerative Medicine for the Study and Treatment of Cholangiopathies

Generation of Organoids from Mouse Extrahepatic Bile Ducts